229 related articles for article (PubMed ID: 33327623)
41. Injury of Adult Zebrafish Expressing Acvr1l
LaBonty M; Pray N; Yelick PC
Zebrafish; 2018 Dec; 15(6):536-545. PubMed ID: 30183553
[TBL] [Abstract][Full Text] [Related]
42. Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.
Barruet E; Hsiao EC
Bone; 2018 Apr; 109():162-167. PubMed ID: 28716551
[TBL] [Abstract][Full Text] [Related]
43. Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2.
Williams E; Bullock AN
Bone; 2018 Apr; 109():251-258. PubMed ID: 28918311
[TBL] [Abstract][Full Text] [Related]
44. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.
Wang H; Lindborg C; Lounev V; Kim JH; McCarrick-Walmsley R; Xu M; Mangiavini L; Groppe JC; Shore EM; Schipani E; Kaplan FS; Pignolo RJ
J Bone Miner Res; 2016 Sep; 31(9):1652-65. PubMed ID: 27027798
[TBL] [Abstract][Full Text] [Related]
45. Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva.
Katagiri T; Tsukamoto S; Kuratani M
Bone; 2018 Apr; 109():241-250. PubMed ID: 28754575
[TBL] [Abstract][Full Text] [Related]
46. Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.
Kaplan FS; Zeitlin L; Dunn SP; Benor S; Hagin D; Al Mukaddam M; Pignolo RJ
Bone; 2018 Apr; 109():281-284. PubMed ID: 29241828
[TBL] [Abstract][Full Text] [Related]
47. Heterotopic Ossification: A Comprehensive Review.
Meyers C; Lisiecki J; Miller S; Levin A; Fayad L; Ding C; Sono T; McCarthy E; Levi B; James AW
JBMR Plus; 2019 Apr; 3(4):e10172. PubMed ID: 31044187
[TBL] [Abstract][Full Text] [Related]
48. Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1.
Whyte MP; Wenkert D; Demertzis JL; DiCarlo EF; Westenberg E; Mumm S
J Bone Miner Res; 2012 Mar; 27(3):729-37. PubMed ID: 22131272
[TBL] [Abstract][Full Text] [Related]
49. A Door Opens for Fibrodysplasia Ossificans Progressiva.
Katagiri T
Trends Biochem Sci; 2016 Feb; 41(2):119-121. PubMed ID: 26654278
[TBL] [Abstract][Full Text] [Related]
50. Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva.
Lees-Shepard JB; Yamamoto M; Biswas AA; Stoessel SJ; Nicholas SE; Cogswell CA; Devarakonda PM; Schneider MJ; Cummins SM; Legendre NP; Yamamoto S; Kaartinen V; Hunter JW; Goldhamer DJ
Nat Commun; 2018 Feb; 9(1):471. PubMed ID: 29396429
[TBL] [Abstract][Full Text] [Related]
51. Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification.
Agarwal S; Loder SJ; Breuler C; Li J; Cholok D; Brownley C; Peterson J; Hsieh HH; Drake J; Ranganathan K; Niknafs YS; Xiao W; Li S; Kumar R; Tompkins R; Longaker MT; Davis TA; Yu PB; Mishina Y; Levi B
Mol Ther; 2017 Aug; 25(8):1974-1987. PubMed ID: 28716575
[TBL] [Abstract][Full Text] [Related]
52. An Adult Zebrafish Model of Fibrodysplasia Ossificans Progressiva.
LaBonty M; Yelick PC
Methods Mol Biol; 2019; 1891():155-163. PubMed ID: 30414131
[TBL] [Abstract][Full Text] [Related]
53. Molecular and cellular mechanisms of heterotopic ossification.
Ramirez DM; Ramirez MR; Reginato AM; Medici D
Histol Histopathol; 2014 Oct; 29(10):1281-5. PubMed ID: 24796520
[TBL] [Abstract][Full Text] [Related]
54. Chronic ulcers, calcification and calcified fibrous tumours: phenotypic manifestations of a congenital disorder of heterotopic ossification.
Kupitz S; Enoch S; Harding KG
Int Wound J; 2007 Sep; 4(3):273-80. PubMed ID: 17924883
[TBL] [Abstract][Full Text] [Related]
55. Progressive osseous heteroplasia in a 10-year-old male child.
Singh GK; Verma V
Indian J Orthop; 2011 May; 45(3):280-2. PubMed ID: 21559111
[TBL] [Abstract][Full Text] [Related]
56. A new mouse model of post-traumatic joint injury allows to identify the contribution of Gli1+ mesenchymal progenitors in arthrofibrosis and acquired heterotopic endochondral ossification.
Magallanes J; Liu NQ; Zhang J; Ouyang Y; Mkaratigwa T; Bian F; Van Handel B; Skorka T; Petrigliano FA; Evseenko D
Front Cell Dev Biol; 2022; 10():954028. PubMed ID: 36092701
[TBL] [Abstract][Full Text] [Related]
57. Report of a man with heterotopic ossification of the legs.
García-Arpa M; Flores-Terry MA; Franco-Muñoz M; Villasanti-Rivas N; González-Ruiz L; Banegas-Illescas ME
Reumatol Clin (Engl Ed); 2020; 16(4):300-302. PubMed ID: 29793769
[TBL] [Abstract][Full Text] [Related]
58. Heterotopic Mesenteric Ossification With Trilineage Hematopoiesis.
Martinbianco EM; Lilley CM; Grech J; Mirza KM; Chen X
Cureus; 2022 Apr; 14(4):e24620. PubMed ID: 35664416
[TBL] [Abstract][Full Text] [Related]
59. Heterotopic Ossification: Clinical Features, Basic Researches, and Mechanical Stimulations.
Xu Y; Huang M; He W; He C; Chen K; Hou J; Huang M; Jiao Y; Liu R; Zou N; Liu L; Li C
Front Cell Dev Biol; 2022; 10():770931. PubMed ID: 35145964
[TBL] [Abstract][Full Text] [Related]
60. Intra-abdominal heterotopic ossification of the peritoneum following traumatic splenic rupture.
Ioannidis O; Sekouli A; Paraskevas G; Kotronis A; Chatzopoulos S; Papadimitriou N; Konstantara A; Makrantonakis A; Kakoutis E
J Res Med Sci; 2012 Jan; 17(1):92-5. PubMed ID: 23248662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]